Hostname: page-component-848d4c4894-tn8tq Total loading time: 0 Render date: 2024-06-20T16:05:41.007Z Has data issue: false hasContentIssue false

Bilirubin Metabolism — Preliminary Investigation

Published online by Cambridge University Press:  18 September 2015

A. Barbeau*
Affiliation:
Clinical Research Institute of Montreal; the Hôpital Hôtel-Dieu de Montreal; and the Centre Hospitalier Universitaire de Sherbrooke
G. Breton
Affiliation:
Clinical Research Institute of Montreal; the Hôpital Hôtel-Dieu de Montreal; and the Centre Hospitalier Universitaire de Sherbrooke
B. Lemieux
Affiliation:
Clinical Research Institute of Montreal; the Hôpital Hôtel-Dieu de Montreal; and the Centre Hospitalier Universitaire de Sherbrooke
R.F. Butterworth
Affiliation:
Clinical Research Institute of Montreal; the Hôpital Hôtel-Dieu de Montreal; and the Centre Hospitalier Universitaire de Sherbrooke
*
Clinical Research Institute of Montreal, 110 Pine Avenue West, Montreal, H2W 1R7 Quebec, Canada
Rights & Permissions [Opens in a new window]

Summary:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

In our studies, high total bilirubin values in the plasma were noted in cases of Friedreich's ataxia. A bimodal distribution of the values indicated the possible presence of two subgroups of patients. In these kindred, we demonstrated an elevation in unconjugated bilirubin with features similar to those reported in Gilbert's syndrome: normal liver function tests, elevation after fasting and day to day variability. We also report preliminary experiments indicating that bilirubin levels may be taurine dependent. We postulate that the defect could be a secondary component of the ataxic disease, possibly indicating a defect in membrane transport.

Type
Quebec Cooperative Study of Friedreich's Ataxia
Copyright
Copyright © Canadian Neurological Sciences Federation 1976

References

REFERENCES

Acocella, G., Nicolis, F.B. and Tenconi, L.T. (1965). Effect of intravenous infusion of rifamycin SV on excretion of bilirubin, bromsulphalein, and indoxyanine green in man. Gastroent., 49, 521525.CrossRefGoogle ScholarPubMed
Anwer, M.S. and Gronwall, R. (1976). A compartment model for bilirubin kinetics in isolated perfused rat liver. Can. J. Physiol. Pharmacol., 54, 277286.CrossRefGoogle ScholarPubMed
Arias, I.M. (1962). Chronic unconjugated hyperbilirubinemia without overt signs of hemolysis in adolescents and adults. J. Clin. Invest., 41, 2233.CrossRefGoogle ScholarPubMed
Arias, I.M., Gartner, L.M., Cohen, M., Ezzer, J.B. and Levi, A.J. (1969). Chronic nonhymolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency. Am. J. Medicine, 47, 395409.CrossRefGoogle ScholarPubMed
Barbeau, I., Inoue, N., Tsukada, Y. and Butterworth, R.F. (1975). The neuropharmacology of taurine. Life Sciences, 17, 669678.CrossRefGoogle ScholarPubMed
Billing, B.H., Williams, R. and Richards, T.G. (1964). Defects in hepatic transport of bilirubin in congenital hyperbilirubinaemia: An analysis of plasma bilirubin disappearance curves. Clin. Sci., 27, 245257.Google ScholarPubMed
Crigler, J.F. and Najjar, V.A., (1952). Congenital familial non-hemolytic jaundice with kernicterus. Pediatrics, 10, 169170.Google ScholarPubMed
Damashek, W. and Singer, K. (1941). Familial non-hemolytic jaundice. Arch. Int. Med., 69, 259285.Google Scholar
Da Silva, L.C, De Godoy, A., Meades, F.T.Leite, G.M. and Pontes, J.F. (1960). Indirect reacting hyperbilirubinaemia after protosystemic shunt: its relation to other complications. Gastroent., 39, 605614.CrossRefGoogle Scholar
Foulk, W.T., Butt, H.R., Owen, C.A., Whitcomb, F.F. and Mason, H.L. (1959). Constitutional hepatic dysfunction (Gilbert’s disease): Its natural history and related syndromes. Medicine, 38, 2546.CrossRefGoogle ScholarPubMed
Fujihira, E., Takahashi, N., Matsui, T., Hattori, Y. and Arai, T. (1971). Plasma and tissue concentrations of free taurine and amino acids in fasted, and hyperor hypothyroid diet fed rats. Chem. Pharm. Bull., 19, 424428.CrossRefGoogle Scholar
Gilbert, N.A. and Lereboullet, P. (1907). La Cholémié simple familiale. Sem. Med. (Paris), 11, 241243.Google Scholar
Huxtable, R. and Barbeau, A. (Eds.) (1976). Taurine, Raven Press, New York, pp. 1398.Google ScholarPubMed
Jacobsen, J.G. and Smith, L.L.H. (1968). Biochemistry and physiology of taurine and taurine derivatives. Physiol. Rev., 48, 424511.CrossRefGoogle ScholarPubMed
Kalk, H. (1955). Uber die posthepatitische hyperbilirubinàmie. Gastroenterologia, 84, 207.CrossRefGoogle Scholar
Kornberg, A. (1942). Latent liver disease in persons recovering from catarrhal jaundice and in otherwise normal medical students as revealed by the bilirubin excretion test. J. Clin. Invest., 21, 299.CrossRefGoogle ScholarPubMed
Malloy, H. and Evelyn, K. (1937). Determination of bilirubin with the photoelectric colorimeter. J. Biol. Chem., 119, 481.CrossRefGoogle Scholar
Ohshima, T. and Fujihira, E. (1971). Effect of taurine on metabolic function of isolated, perfused rat liver. Chem. Pharm. Bull., 19, 20202025.CrossRefGoogle Scholar
Powell, L.W., Hemingway, E., Billing, B.H. and Sherlock, S. (1967). Idiopathic unconjugated hyperbilirubinemia (Gilbert’s syndrome). – a study of 42 families. New Engl. J. Med., 23, 11081112.CrossRefGoogle Scholar
Redeker, A.G., Richard, D. and Felsher, B.F. (1970). The reciprocal relationship between caloric intake and degree of hyperbilirubinemia in Gilbert’s syndrome. Gastroent., 58, 303.Google Scholar
Sicot, C. (1975). La maladie de Gilbert et la maladie de Dubin-Johnson. Le Concours Médical, 97(35), 54075413.Google Scholar
Smith, P.M., Middleton, J.E. and Williams, R. (1967). Studies on the familial incidence and clinical history of patients with chronic unconjugated hyperbilirubinemia. Gut., 8, 449.CrossRefGoogle Scholar
Spaeth, D.G. and Schneider, D.L. (1974). Taurine synthesis, concentration and bile salt conjugation in rat, guinea pig and rabbit. Proc. Soc. Exp. Biol. Med., 147, 855858.CrossRefGoogle ScholarPubMed